News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Paola Alberti: Grateful to be part of MASCC’s supportive care 2030 movement paper
Photo from Paola Alberti/LinkedIn
Sep 17, 2024, 00:49

Paola Alberti: Grateful to be part of MASCC’s supportive care 2030 movement paper

Paola Alberti, Assistant Professor in Human Anatomy at University of Milano-Bicocca, shared the following post on LinkedIn:

“Check out the The Multinational Association of Supportive Care in Cancer (MASCC) supportive care 2030 movement paper!

Grateful to be part of this effort!”

Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study

Authors: Raymond Javan Chan, Reegan Knowles, Fredrick D. Ashbury, Joanne Bowen, Alexandre Chan, Melissa Chin, Ian Olver, Carolyn Taylor, Stacey Tinianov, Paola Alberti, Paolo Bossi, Norman Brito-Dellan, Tim Cooksley, Gregory Brian Crawford, Niharika Dixit, Margaret I. Fitch, Jason L. Freedman, Pamela K. Ginex, Nicolas H. Hart, Daniel L. Hertz, Michael Jefford, Bogda Koczwara, Tateaki Naito, Andrea Dahlman Orsey, Christina H. Ruhlmann, Nikolaos Tsoukalas, Corina van den Hurk, Ysabella Van Sebille, Hannah Rose Wardill, Florian Scotte, Maryam Lustberg.

Paola Alberti: Grateful to be part of MASCC’s supportive care 2030 movement paper

Source: Paola Alberti/LinkedIn

Alexandre Chan cancer cancer care Cancer research Carolyn Taylor Delphi study Fredrick D. Ashbury global healthcare Healthcare Excellence Ian Olver Joanne Bowen MASCC Melissa Chin Multinational Association of Supportive Care in Cancer OncoDaily Oncology Paola Alberti Paolo Bossi patient support Raymond Javan Chan Reegan Knowles Stacey Tinianov Supportive Cancer Care Supportive Care 2030 Movement
Special Coverage
Drugs
Dec 21, 2024, 10:38
Hanna Foster: Market cap and Revenue of Cancer NGS Drugs providers in 2024
Insight
Dec 21, 2024, 10:35
30 Years of Leadership in Immuno-Oncology - Agenus
Blog
Dec 21, 2024, 10:19
A Portrait of Germline Pathogenic Variants in Breast Cancer Genes in Brazil
Dialogues
Dec 21, 2024, 10:09
Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market
Blog
Dec 21, 2024, 09:22
When the world of science and sports comes together! - The V Foundation
Blog
Dec 21, 2024, 09:16
Timely cancer treatment isn’t just a goal, It’s a necessity - European Cancer Organisation
Science
Dec 21, 2024, 09:06
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial
Blog
Dec 21, 2024, 09:00
Miriam Mutebi: Does Nipple and Areola Size Matter?
Science
Dec 21, 2024, 08:51
Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis
Science
Dec 21, 2024, 08:48
Oncology Brothers: Another ALK inhibitor gets FDA approval
Science
Dec 21, 2024, 08:42
Eric K. Singhi: Decoding clinical trial jargon
Science
Dec 21, 2024, 08:37
Gustavo Viani: The Role of Radiotherapy on the management of HCC